Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications

NOVATO, California - Claims to Cover Therapeutic Delivery Across Blood-Brain Barrier

Raptor Pharmaceuticals Corp. (”Raptor” or the “Company”) (OTC Bulletin Board: RPTP) today announced that the United States Patent and Trademark Office (”USPTO”) has issued two Notices of Allowance for U.S. Patent Application Nos. 10/812,849 and 11/202,566, titled “Methods of increasing delivery of active agents to brain comprising administering receptor-associated protein (”RAP”) fragments conjugated to active agents.”

Consumers Rank Wireless Power Charging in Top 20% of Lifestyle Demands According to Market Research

HONG KONG - Wireless Power Consortium pursues universal wireless power to fulfill consumer need

Working Towards ‘Counting Malaria Out’ Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance

LAUSANNE, Switzerland - World Malaria Day Events Held in Nairobi, London, Washington

To honor the theme for World Malaria Day on 4/25, ‘Counting Malaria Out,’ Vestergaard Frandsen is stepping up production of its best selling bed net, called PermaNet(R), and introducing a new version that is effective against insecticide resistant mosquitoes.

Qnective Inc: Mobile Telephony With Optimum Security

ZURICH, Switzerland - The company, Qnective Inc, has launched its “Qtalk secureServer” software solution which allows companies to make eavesdrop-proof phone calls to commercially available mobile phones. Qnective is a leading provider of mobile Voice over IP voice and data solutions for the most demanding security requirements.

Business Pros Waste Five Hours a Week Arranging Meetings

ZURICH, Switzerland - Meeting Inefficiencies Cost National Economies Billions Each Year and More Than Half the Working Week

Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure

BASEL, Switzerland - New data published today in a major peer-reviewed journal, Annals of Internal Medicine, show that re-treatment with Pegasys(R) (peginterferon alfa-2a) plus Copegus(R) (ribavirin) provides previously-treated hepatitis C patients a second chance for a cure. The study results demonstrated that patients most likely to respond to re-treatment could be identified after only 12 weeks, allowing patients and their doctors to be confident early on about the likelihood of success.(1)

Procter & Gamble in Geneva Holds Two-Day Recruitment Drive Bringing Together Some Thirty European Students From Top Graduate Schools and Universities - Launching a Completely New Recruitment Process

GENEVA, Switzerland - In Line With its Recruitment Policy, Procter & Gamble in Geneva is Appointing Around 150 People per Year, Half of Whom Already Reside in the Region

ACM Signs Partnership With ERI Bancaire

GENEVA, Switzerland - Leaders in their respective fields, ACM and ERI Bancaire have finalized a partnership for the implementation of the esteemed Olympic Banking System applications software.

RapidShare Expands Reseller Network

CHAM, Switzerland - New Partners in Northern and Eastern Europe, Central and South America, the Middle East and Asia

Ice Hockey World Championships in Switzerland - Full Information at a Glance

BERN, Switzerland - The swissinfo.ch internet platform is reporting on the Ice Hockey World Championships in Switzerland with a special web page. The dossier contains information on the matches, looks behind the scenes and presents background reports on the competition. Briefings on the 2009 IIHF World Championships in Switzerland are available in English, German, French, Italian and Russian.

Cablecom Selects Patton SmartNode(TM) for Euro-ISDN VoIP and Data Service

BERN, Switzerland - In the “connect PBX” converged-IP service for SMEs, Switzerland’s largest cable network relies on SmartNode(TM) VoIP CPE to satisfy the stringent demands of classic ISDN users.

Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

NOVATO, California - Raptor Pharmaceuticals Corp. (”Raptor” or the “Company”) (OTC Bulletin Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D., Ph.D., as Chief Medical Officer (”CMO”). Dr. Rioux will be responsible for the clinical and regulatory advancement of Raptor’s clinical-stage drug development programs.

More Executives See Signs of Recovery Following March Stock Market Rally

LOS ANGELES - Despite Acknowledging the ‘Severe Recession,’ Percentage of Executives Who Believe the Economy is Recovering Nearly Doubled in March -

Bio-Design Computer Mouse

ZURICH - The computer mouse has now been around for 40 years and has become a tool that many people work with for hours each day. The ergonomically-designed ‘HandshoeMouse’ is an especially comfortable and healthy version. Its innovative design has been developed by two Dutch universities and prevents the user suffering from a ‘mouse arm’. It comes in three sizes and a slick wireless version is also available.

International Press Conference: “The World Faces Dire Food Shortages”

ZURICH, Switzerland - An Invitation to the Launch of “Food First”

An Urgent Call to Action by “The Humboldt Forum for Food and Agriculture”

Qnective Inc. Appoints Two Top Specialists to its Advisory Board

ZURICH - Qnective Inc., a U.S. public company, headquartered in Zurich, Switzerland, is appointing Jose Collazo and Paul Barry to its Advisory Board as of 1 April 2009. These appointments provide Qnective Inc. with a strong basis on which to successfully further expand its activities and market position.

Promoting Environmental Health Interventions: International Medical Corps and Earth Council Geneva Launch Strategic Partnership

LOS ANGELES and GENEVA, Switzerland - In an effort to find sustainable solutions to global environmental health problems International Medical Corps and Earth Council Geneva have launched a strategic partnership that will benefit communities impacted by the severe scarcity of vital resources. The new alliance, which will take place on both the global and country levels, will focus on strengthening the quality, accountability, and efficiency of water, sanitation, hygiene, and other environmental health interventions.

Palonosetron “Preferred” 5-HT3 Antagonist for Emesis Prevention in Oncology Patients Receiving Highly Emetogenic Chemotherapy

LUGANO, Switzerland - A new release of the NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology on Antiemesis recommends palonosetron as the “preferred” 5-HT3 antagonist in combination with aprepitant and dexamethasone for prevention of emesis in highly emetic risk chemotherapy.

SunGard Acquires Genix Systems AG

GENEVA - SunGard announced today that it has strengthened its position in the Swiss private banking sector by acquiring Genix Systems AG, a Zurich-based provider of customer information systems to small and medium-sized private banks. Genix will be integrated into SunGard’s banks business and its flagship solution, WinDekis, will become part of SunGard’s Ambit Apsys private banking solution, with which it already shares a number of common customers. The acquisition, the terms of which were not disclosed, is not expected to have a material impact on SunGard’s financial results.

Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray

GENEVA, Switzerland - Viroblock SA has announced today that the first generation of
VCCD Tech antiviral nasal spray formulation is active against human
influenza. Viroblock’s patented Cholesterol Catalytic Depletion Technology
(VCCD Tech) inactivates enveloped viruses during the extra-cellular phase, by
altering and destabilizing cholesterol-rich viral envelopes.

Merck Serono: New Phase III Data for Cladribine Tablets to be Presented at the American Academy of Neurology 61st Annual Meeting in April 2009

GENEVA, Switzerland - CLARITY (CLAdRIbine tablets Treating MS OrallY) Study Data to be
Presented as Late-Breaking Oral Presentation

BaselWorld: Results of the WorldWatchReport 2009 Revealed

GENEVA - Internet demand for counterfeit goods is growing by 6% in the United
States, whereas it is shrinking across Europe.

Hublot and WISeKey Revolutionize BASELWORLD2009 With its Breakthrough Technology Against Counterfeiting

ZURICH, Switzerland - Yesterday at BASELWORLD 2009, WISeKey, and Hublot announced a world first
at BaselWorld 2009 demonstrating an unique breakthrough solution that will
help reduce counterfeiting among the luxury watch industry. This solution
arrives during a period on which the watch industry is also impacted by the
crisis and needs to reassure its clients.

RapidShare Hosts Avira Antivirus Download for PC WELT (IDG Magazine Media GmbH)

CHAM, Switzerland - 250,000 Downloads Within Two Hours

The download of security software Avira Antivirus Personal 9 Free for PC
WELT, a magazine published by IDG Magazine Media GmbH, was hosted by
RapidShare. The software was downloaded 250,000 times from the site
www.pcwelt.de/specials/antivir within the first two hours. In total,
RapidShare provided 80 terabytes of data within one week and processed 10
gigabytes of data traffic per second during peak times.

Ascom Announces the Acquisition of TEMS From Ericsson - Creating a Global Leader in Mobile Network Testing

ZURICH - Ascom has signed a binding agreement to purchase TEMS, a test business,
from Ericsson for a total consideration of CHF 190 million in cash (on a debt
and cash-free basis).

Merck Serono Launches Strategic Venture Capital Fund

GENEVA, Switzerland - New Venture Capital Fund Will Invest in Biotech Start-up Companies
Focused on Merck Serono’s Core Therapeutic Areas

Palonosetron Warrants Adequate Caloric Intake in Oncology Patients Receiving High Emetogenic Chemotherapy

ZURICH, Switzerland - A new, innovative study shows that a single dose of palonosetron, the
second generation 5-HT3 antagonist, plus dexamethasone not only prevents
chemotherapy-induced nausea and vomiting (CINV), but also allows adequate
caloric intake in oncology patients. Data presented today at the ESMO
Symposium on Cancer and Nutrition in Zurich, Switzerland

Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis

GENEVA, Switzerland - Merck Serono and Fast Forward Agree to Work Together to Speed Research
and Development on a Select Group of High Potential MS Research Projects With
Support of up to $19 Million in Funding

Market Launch of True Carrier-supported Mobile VoIP

ZURICH - BT inmo Chooses Qnective Inc

Qnective Inc., a U.S. public company, headquartered in Zurich,
Switzerland, can post one of its first significant triumphs. BT inmo, a
wholly owned subsidiary of BT Telecommunications Plc, has purchased a licence
for global sales of mobile VoIP solutions from Qnective.

TAG Heuer Selects IC-Agency for International Search Engine Optimization

GENEVA - TAG Heuer, the well-known luxury watch brand belonging to LVMH
Moët Hennessy - Louis Vuitton, the global leader in luxury brands, has chosen
IC-Agency, a market leader in luxury digital marketing, to sustainably
increase its Internet presence. The strategy deployed encompasses not only
Google, Yahoo! and MSN, but also search engines such as Baidu and Yandex,
market leaders in the high-growth markets of China and Russia, respectively.

Simbionix Increases Product Offerings for OB/GYN Physicians

CLEVELAND and ZURICH, Switzerland - Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons
the Most Advanced Training System for Endoscopic Surgery

Neo Booking SA: Launch of BookingDooH.com - The Only Global “Digital-out-of-Home” Online Planning and Booking Platform

GENEVA, Switzerland - Neo Booking SA, is launching the first global online planning and booking
platform for “digital-out-of-home” advertising, called BookingDooH
(www.bookingdooh.com).

Protected by Comment Guard Pro